Search by Drug Name or NDC

    NDC 54859-0505-04 Tusnel Diabetic 10; 100 mg/5mL; mg/5mL Details

    Tusnel Diabetic 10; 100 mg/5mL; mg/5mL

    Tusnel Diabetic is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 54859-0505
    Product ID 54859-505_7bb71b9d-9085-4df4-addb-2f61e1dd658a
    Associated GPIs 43997002520910
    GCN Sequence Number 000652
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53491
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Tusnel Diabetic
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 10; 100
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 54859-0505-04 (54859050504)

    NDC Package Code 54859-505-04
    Billing NDC 54859050504
    Package 118 mL in 1 BOTTLE (54859-505-04)
    Marketing Start Date 2003-12-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01381
    Pricing Unit ML
    Effective Date 2023-07-19
    NDC Description TUSNEL DIABETIC LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 66b3c094-809e-4d2c-bc15-46563de685cb Details

    Revised: 7/2022